|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S1
|
$363,313
|
$3,633
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S2
|
$113,227
|
$1,132
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S3
|
$327,884
|
$3,279
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S4
|
$88,172
|
$882
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
5P30CA023074-30
|
$4,124,404
|
$41,244
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Adult Leukemia Research Center
|
2P01CA018029-32
|
$5,086,500
|
$1,271,625
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Regional Oncology Research Center
|
3P30CA006973-45S1
|
$231,549
|
$9,262
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-45S2
|
$126,362
|
$5,054
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-45
|
$7,564,613
|
$302,585
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Molecular Studies of Bone Marrow Failure
|
5R01CA105312-04
|
$514,833
|
$514,833
|
BESSLER, MONICA
|
WASHINGTON UNIVERSITY
|
|
Program on Molecular and Cellular Mechanisms of Tumorigenesis
|
5P01CA016519-32
|
$1,858,387
|
$185,839
|
BOEKE, Jef
|
JOHNS HOPKINS UNIVERSITY
|
|
University of Michigan Comprehensive Cancer Center CCOP*
|
3U10CA074648-06S1
|
$14,723
|
$147
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Cell Survival and Cancer
|
5P01CA078890-08
|
$1,371,447
|
$685,724
|
CALABRETTA, BRUNO
|
THOMAS JEFFERSON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016087-27
|
$2,563,433
|
$333,246
|
CARROLL, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
The Role of BCR/ABL in Regulating DNA Repair
|
5R01CA100885-04
|
$246,470
|
$24,647
|
CARROLL, MARTIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Specialized Cancer Center Support Grant
|
2P30CA023100-23
|
$3,966,000
|
$317,280
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-23S1
|
$115,875
|
$9,270
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-23S2
|
$92,700
|
$7,416
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
THERAPY OF CML
|
5P01CA049639-19
|
$3,552,240
|
$3,552,240
|
CHAMPLIN, RICHARD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Role of Redox Dependent Signaling in Leukemia
|
1R01CA115811-01A2
|
$292,600
|
$292,600
|
CHANDRA, JOYA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Signaling and targeting of FGFR1 fusions in 8p11 myeloproliferative syndrome
|
5R01CA120272-02
|
$263,700
|
$263,700
|
Chen, Jing
|
EMORY UNIVERSITY
|
|
Hematopoietic Stem Cells for Transplantation
|
3P01CA070970-09S1
|
$775,678
|
$232,703
|
CIVIN, CURT
|
JOHNS HOPKINS UNIVERSITY
|
|
SEARCH FOR SELECTIVE THERAPY OF CML
|
5P01CA064593-12
|
$1,335,531
|
$1,335,531
|
CLARKSON, BAYARD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
NR4A Nuclear Receptor Function in Leukemia
|
5R01CA111411-02
|
$258,529
|
$258,529
|
CONNEELY, ORLA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Genetic Analysis of Myeloproliferative Disease
|
2R01CA076167-06A2
|
$334,564
|
$334,564
|
COWELL, JOHN
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Mechanisms of Leukemogenesis in Down Syndrome
|
2R01CA101774-05
|
$305,707
|
$152,854
|
CRISPINO, JOHN
|
NORTHWESTERN UNIVERSITY
|
|
AbI-Abi signaling in neoplastic hematopoiesis
|
5R01CA094921-06
|
$243,183
|
$243,183
|
DAI, ZONGHAN
|
TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-33S1
|
$110,040
|
$1,100
|
DIASIO, ROBERT
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-33S2
|
$98,300
|
$983
|
DIASIO, ROBERT
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-33
|
$5,104,634
|
$51,046
|
Diasio, Robert
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
OHSU Cancer Institute
|
3P30CA069533-11S1
|
$67,584
|
$4,055
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Cancer Institute
|
5P30CA069533-11
|
$1,133,755
|
$68,025
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Chronic Myelogenous Leukemia and Bcr-Abl Substrates
|
5R01CA065823-13
|
$310,124
|
$310,124
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Cancer Center Core Support Grant
|
3P30CA016086-32S1
|
$89,905
|
$899
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
5P30CA016086-32
|
$6,392,142
|
$63,921
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA091842-07S1
|
$85,134
|
$1,703
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-07S2
|
$238,995
|
$4,780
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA091842-07
|
$3,978,214
|
$79,564
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
2P30CA016359-29
|
$1,871,000
|
$18,710
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
North American Juvenile Myelomonocytic Leukemia Project
|
5R01CA095621-05
|
$317,003
|
$317,003
|
EMANUEL, PETER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
New Approaches to the Biology and Treatment of MDS
|
5P01CA108631-03
|
$1,917,919
|
$1,917,919
|
ESTEY, ELIHU
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
mTOR Signaling In Chronic Myelogenous Leukemia
|
5R01CA107041-03
|
$228,465
|
$228,465
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
UT M.D. Anderson Cancer Center
|
2U10CA045809-19
|
$1,362,206
|
$108,976
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-04
|
$2,163,323
|
$540,831
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation Therapy
|
Z01 SC 010288
|
$790,216
|
$39,511
|
Fowler, Daniel
|
CCR (NCI)
|
|
Allogeneic lymphocyte infusions to treat myeloid cancers
|
5R21CA121588-02
|
$282,657
|
$282,657
|
FUCHS, EPHRAIM
|
JOHNS HOPKINS UNIVERSITY
|
|
Developing Nucleic Acid Therapeutics
|
5R01CA101859-05
|
$267,510
|
$133,755
|
Gewirtz, Alan
|
UNIVERSITY OF PENNSYLVANIA
|
|
Mechanism of combined 'epigenetic therapy' in myeloid malignancies
|
1R01CA125635-01A1
|
$520,405
|
$260,203
|
GORE, STEVEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Arsenic Trioxide in Primary Curative APL Therapy
|
5R01CA100904-04
|
$419,060
|
$209,530
|
GORE, STEVEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Role of Lipocalin 24p3 in Apoptosis and Leukemia
|
5R01CA115817-02
|
$252,065
|
$252,065
|
GREEN, MICHAEL
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $36,474,515
|